JP2020504186A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020504186A5 JP2020504186A5 JP2019557681A JP2019557681A JP2020504186A5 JP 2020504186 A5 JP2020504186 A5 JP 2020504186A5 JP 2019557681 A JP2019557681 A JP 2019557681A JP 2019557681 A JP2019557681 A JP 2019557681A JP 2020504186 A5 JP2020504186 A5 JP 2020504186A5
- Authority
- JP
- Japan
- Prior art keywords
- acetonitrile
- cyclohexyl
- pyridin
- imidazole
- hydroxyethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 33
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 20
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 10
- 150000002460 imidazoles Chemical class 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 8
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 4
- 229910052805 deuterium Inorganic materials 0.000 claims 4
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 210000000987 immune system Anatomy 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 claims 1
- PQHPWXJREYZBAC-MGCOHNPYSA-N NC=1C(=CC(=NC=1)Cl)N[C@@H]1CC[C@H](CC1)CC#N Chemical group NC=1C(=CC(=NC=1)Cl)N[C@@H]1CC[C@H](CC1)CC#N PQHPWXJREYZBAC-MGCOHNPYSA-N 0.000 claims 1
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 230000003831 deregulation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17151020.9 | 2017-01-11 | ||
| EP17151020 | 2017-01-11 | ||
| PCT/EP2018/050548 WO2018130563A1 (en) | 2017-01-11 | 2018-01-10 | Novel amino-imidazopyridine derivatives as janus kinase inhibitors and pharmaceutical use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020504186A JP2020504186A (ja) | 2020-02-06 |
| JP2020504186A5 true JP2020504186A5 (enExample) | 2021-02-12 |
| JP7009504B2 JP7009504B2 (ja) | 2022-01-25 |
Family
ID=57777557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019557681A Active JP7009504B2 (ja) | 2017-01-11 | 2018-01-10 | ヤヌスキナーゼ阻害剤としての新規アミノイミダゾピリジン誘導体及びそれらの医薬としての使用 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10703751B2 (enExample) |
| EP (1) | EP3568396B1 (enExample) |
| JP (1) | JP7009504B2 (enExample) |
| KR (1) | KR102548543B1 (enExample) |
| CN (1) | CN110167938B (enExample) |
| AU (1) | AU2018208516B2 (enExample) |
| CA (1) | CA3045567A1 (enExample) |
| CY (1) | CY1123864T1 (enExample) |
| DK (1) | DK3568396T3 (enExample) |
| ES (1) | ES2846741T3 (enExample) |
| HR (1) | HRP20210095T1 (enExample) |
| HU (1) | HUE052720T2 (enExample) |
| IL (1) | IL267829B (enExample) |
| LT (1) | LT3568396T (enExample) |
| MX (1) | MX389378B (enExample) |
| MY (1) | MY195576A (enExample) |
| NZ (1) | NZ754922A (enExample) |
| PL (1) | PL3568396T3 (enExample) |
| PT (1) | PT3568396T (enExample) |
| RS (1) | RS61317B1 (enExample) |
| RU (1) | RU2019125177A (enExample) |
| SI (1) | SI3568396T1 (enExample) |
| TW (1) | TWI760419B (enExample) |
| UA (1) | UA123972C2 (enExample) |
| WO (1) | WO2018130563A1 (enExample) |
| ZA (1) | ZA201904190B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| ES2922379T3 (es) | 2016-12-16 | 2022-09-14 | Janssen Pharmaceutica Nv | Compuestos de imidazo[4,5,D]pirrolo[2,3,B]piridina como inhibidores de Janus quinasas |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| WO2020007698A1 (en) * | 2018-07-06 | 2020-01-09 | Leo Pharma A/S | Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereof |
| WO2021040502A1 (ko) * | 2019-08-30 | 2021-03-04 | 주식회사 티에스디라이프사이언스 | 이미다조피리딘 유도체 및 이를 유효성분으로 함유하는 약학적 조성물 |
| AU2022233254A1 (en) | 2021-03-11 | 2023-10-26 | Janssen Pharmaceutica Nv | Lorpucitinib for use in the treatment of jak mediated disorders |
| CN119569971B (zh) * | 2025-02-07 | 2025-05-27 | 吉林大学 | 一种用于蛋白质磷酸化和棕榈酰化修饰同时筛选的Janus材料的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101981033B (zh) * | 2008-02-06 | 2015-02-04 | 百时美施贵宝公司 | 用作激酶抑制剂的取代的咪唑并哒嗪化合物 |
| KR20140015162A (ko) | 2010-01-12 | 2014-02-06 | 에프. 호프만-라 로슈 아게 | 트라이사이클릭 헤테로사이클릭 화합물, 조성물 및 이의 사용 방법 |
| CN103168032A (zh) * | 2010-08-05 | 2013-06-19 | 安美基公司 | 抑制间变性淋巴瘤激酶的苯并咪唑和氮杂苯并咪唑化合物 |
| EP2518071A1 (en) * | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Imidazopyridine derivatives as PI3K inhibitors |
| EP2527344A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
| WO2013007768A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors |
| WO2013007765A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Fused tricyclic compounds for use as inhibitors of janus kinases |
| UY34615A (es) | 2012-02-10 | 2013-09-30 | Galapagos Nv | Nuevos compuestos útiles para el tratamiento de enfermedades degenerativas e inflamatorias. |
| CA2888816A1 (en) | 2012-11-01 | 2014-05-08 | Incyte Corporation | Tricyclic fused thiophene derivatives as jak inhibitors |
| CN104955824B (zh) * | 2012-11-20 | 2017-09-22 | 豪夫迈·罗氏有限公司 | 作为含t790m的egfr突变体的抑制剂的氨基嘧啶化合物 |
| CN104098563A (zh) | 2013-04-02 | 2014-10-15 | 山东亨利医药科技有限责任公司 | Jnk抑制剂化合物 |
| CR20160553A (es) | 2014-04-30 | 2017-04-25 | Incyte Corp | Procesos para preparar un inhibidor de jak1 y nuevas formas de este |
| MX390005B (es) | 2016-10-03 | 2025-03-20 | Hangzhou Highlightll Pharmaceutical Co Ltd | Inhibidores selectivos de jak1 novedosos y usos de los mismos. |
| JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
-
2018
- 2018-01-10 SI SI201830191T patent/SI3568396T1/sl unknown
- 2018-01-10 UA UAA201908568A patent/UA123972C2/uk unknown
- 2018-01-10 MY MYPI2019003964A patent/MY195576A/en unknown
- 2018-01-10 RS RS20210044A patent/RS61317B1/sr unknown
- 2018-01-10 RU RU2019125177A patent/RU2019125177A/ru unknown
- 2018-01-10 HR HRP20210095TT patent/HRP20210095T1/hr unknown
- 2018-01-10 LT LTEP18702412.0T patent/LT3568396T/lt unknown
- 2018-01-10 HU HUE18702412A patent/HUE052720T2/hu unknown
- 2018-01-10 NZ NZ754922A patent/NZ754922A/en unknown
- 2018-01-10 CN CN201880006261.0A patent/CN110167938B/zh active Active
- 2018-01-10 PL PL18702412T patent/PL3568396T3/pl unknown
- 2018-01-10 WO PCT/EP2018/050548 patent/WO2018130563A1/en not_active Ceased
- 2018-01-10 DK DK18702412.0T patent/DK3568396T3/da active
- 2018-01-10 PT PT187024120T patent/PT3568396T/pt unknown
- 2018-01-10 MX MX2019008331A patent/MX389378B/es unknown
- 2018-01-10 EP EP18702412.0A patent/EP3568396B1/en active Active
- 2018-01-10 KR KR1020197021697A patent/KR102548543B1/ko active Active
- 2018-01-10 AU AU2018208516A patent/AU2018208516B2/en active Active
- 2018-01-10 US US16/477,249 patent/US10703751B2/en active Active
- 2018-01-10 ES ES18702412T patent/ES2846741T3/es active Active
- 2018-01-10 JP JP2019557681A patent/JP7009504B2/ja active Active
- 2018-01-10 CA CA3045567A patent/CA3045567A1/en active Pending
- 2018-01-11 TW TW107101035A patent/TWI760419B/zh active
-
2019
- 2019-06-26 ZA ZA2019/04190A patent/ZA201904190B/en unknown
- 2019-07-03 IL IL267829A patent/IL267829B/en unknown
-
2021
- 2021-02-01 CY CY20211100085T patent/CY1123864T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020504186A5 (enExample) | ||
| AU2023201399B2 (en) | Modulators of the integrated stress pathway | |
| JP2014513110A5 (enExample) | ||
| TWI810582B (zh) | 酪胺酸激酶抑制劑 | |
| JP2020183410A5 (enExample) | ||
| JP2017526726A5 (enExample) | ||
| JP2014511893A5 (enExample) | ||
| JP2017509689A5 (enExample) | ||
| JP2016527238A5 (enExample) | ||
| JP2013542256A5 (enExample) | ||
| JP2014139226A5 (enExample) | ||
| JP2013515074A5 (enExample) | ||
| RU2019125177A (ru) | Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение | |
| JP2018537535A5 (enExample) | ||
| JP2019525939A5 (enExample) | ||
| JP2008510770A5 (enExample) | ||
| JP2011500758A5 (enExample) | ||
| JP2019505541A5 (enExample) | ||
| JP2017531038A5 (enExample) | ||
| JP2017524025A5 (enExample) | ||
| JP2009538910A5 (enExample) | ||
| JP2022017461A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| JP2017517538A5 (enExample) | ||
| JP2013507426A5 (enExample) |